{"id":"NCT01673867","sponsor":"Bristol-Myers Squibb","briefTitle":"Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC","officialTitle":"An Open-Label Randomized Phase III Trial of BMS-936558 (Nivolumab) Versus Docetaxel in Previously Treated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-11-02","primaryCompletion":"2015-02-05","completion":"2021-12-17","firstPosted":"2012-08-28","resultsPosted":"2016-02-26","lastUpdate":"2023-02-08"},"enrollment":582,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Non-Squamous Cell Non-small Cell Lung Cancer"],"interventions":[{"type":"BIOLOGICAL","name":"Nivolumab","otherNames":["BMS-936558 (Anti-PD1)"]},{"type":"DRUG","name":"Docetaxel","otherNames":["TaxotereÂ®"]}],"arms":[{"label":"Arm A: Nivolumab","type":"EXPERIMENTAL"},{"label":"Arm B: Docetaxel","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the study is to compare the overall survival of BMS-936558 (Nivolumab) as compared with Docetaxel in subjects with non-squamous cell non-small cell lung cancer (NSCLC) after failure of prior platinum-based chemotherapy","primaryOutcome":{"measure":"Overall Survival (OS) Time in Months for All Randomized Participants at Primary Endpoint","timeFrame":"Randomization until 413 deaths, up to March 2015 (approximately 29 months)","effectByArm":[{"arm":"Nivolumab","deltaMin":12.19,"sd":null},{"arm":"Docetaxel","deltaMin":9.36,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0015"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":7},"locations":{"siteCount":119,"countries":["United States","Argentina","Australia","Austria","Brazil","Canada","Chile","Czechia","France","Germany","Hong Kong","Hungary","Italy","Mexico","Norway","Peru","Poland","Romania","Russia","Singapore","Spain","Switzerland"]},"refs":{"pmids":["37264091","36897427","33449799","30215677","30103096","29408986","29023213","26412456"],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","https://www.bmsstudyconnect.com/s/US/English/USenHome","https://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm","https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html"]},"adverseEventsSummary":{"seriousAny":{"events":172,"n":287},"commonTop":["Fatigue","Nausea","Cough","Decreased appetite","Dyspnoea"]}}